Among other lines of evidence, the connection between obesity, hyperinsulinemia and enhanced cancer risk provides a biologically plausible rationale for a key role of insulin and the INSR in breast cancer initiation and/or progression. The gene discussed is INSR; the disease is hyperinsulinism.